Argenica Therapeutics Limited

ASX:AGN 株式レポート

時価総額：AU$92.2m

Argenica Therapeutics マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Liz Dallimore

最高経営責任者

AU$424.2k

報酬総額

CEO給与比率67.8%
CEO在任期間2.6yrs
CEOの所有権1.3%
経営陣の平均在職期間データなし
取締役会の平均在任期間1.6yrs

経営陣の近況

Recent updates

Argenica Therapeutics (ASX:AGN) Is In A Good Position To Deliver On Growth Plans

Sep 23
Argenica Therapeutics (ASX:AGN) Is In A Good Position To Deliver On Growth Plans

Companies Like Argenica Therapeutics (ASX:AGN) Are In A Position To Invest In Growth

Jan 12
Companies Like Argenica Therapeutics (ASX:AGN) Are In A Position To Invest In Growth

Argenica Therapeutics (ASX:AGN) Is In A Strong Position To Grow Its Business

Jul 20
Argenica Therapeutics (ASX:AGN) Is In A Strong Position To Grow Its Business

Argenica Therapeutics (ASX:AGN) Is In A Strong Position To Grow Its Business

Apr 20
Argenica Therapeutics (ASX:AGN) Is In A Strong Position To Grow Its Business

We're Not Very Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Rate

Nov 30
We're Not Very Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Rate

Argenica Therapeutics (ASX:AGN) Is In A Good Position To Deliver On Growth Plans

Aug 12
Argenica Therapeutics (ASX:AGN) Is In A Good Position To Deliver On Growth Plans

Here's Why We're Not Too Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Situation

Apr 29
Here's Why We're Not Too Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Situation

Here's Why We're Not Too Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Situation

Dec 30
Here's Why We're Not Too Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Situation

We're Not Very Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Rate

Sep 16
We're Not Very Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Rate

CEO報酬分析

Argenica Therapeutics の収益と比較して、Liz Dallimore の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024AU$424kAU$288k

-AU$5m

Mar 31 2024n/an/a

-AU$5m

Dec 31 2023n/an/a

-AU$5m

Sep 30 2023n/an/a

-AU$5m

Jun 30 2023AU$675kAU$250k

-AU$5m

Mar 31 2023n/an/a

-AU$4m

Dec 31 2022n/an/a

-AU$4m

Sep 30 2022n/an/a

-AU$4m

Jun 30 2022AU$337kAU$228k

-AU$4m

Mar 31 2022n/an/a

-AU$3m

Dec 31 2021n/an/a

-AU$3m

Sep 30 2021n/an/a

-AU$2m

Jun 30 2021AU$145kAU$31k

-AU$1m

報酬と市場: Lizの 総報酬 ($USD 275.70K ) は、 Australian市場 ($USD 297.98K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Lizの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Liz Dallimore

2.6yrs

在職期間

AU$424,246

報酬

Dr. Liz Dallimore (B. Sc. (Hons), MBA, PhD, GAICD) serves as Chief Executive Officer of Argenica Therapeutics Limited ands serves as its Managing Director and Director since April 4, 2022. She is a researc...

取締役

名称ポジション在職期間報酬所有権
Liz Dallimore
CEO, MD & Director2.6yrsAU$424.25k1.28%
A$ 1.2m
Dianne Angus
Independent Non-Executive Chairmanless than a yearAU$102.58kデータなし
Geoffrey Donnan
Member of Clinical Advisory Committeeno dataデータなしデータなし
Terence Budge
Independent Non-Executive Director3.8yrsAU$44.40k0.63%
A$ 580.1k
Robert Black
Independent Non-Executive Directorless than a yearデータなし0.020%
A$ 18.0k
Paul Bailey
Member of Clinical Advisory Committeeno dataデータなしデータなし
Tim Phillips
Member of Clinical Advisory Committeeno dataデータなしデータなし
David Blacker
Chairman of Clinical Advisory Committeeno dataデータなしデータなし
Jeffery Saver
Member of Clinical Advisory Committee2.3yrsデータなしデータなし
Mark Etherton
Independent Non-Executive Directorless than a yearデータなしデータなし

1.6yrs

平均在職期間

経験豊富なボード: AGNの 取締役会 は 経験豊富 ではない ( 1.6年の平均在任期間) ため、新しい取締役会が必要であると考えられます。